image
Healthcare - Biotechnology - NASDAQ - US
$ 0.618
-8.36 %
$ 2.76 M
Market Cap
-0.43
P/E
BALANCE SHEET
4.32 M ASSETS
-46.21%
655 K LIABILITIES
-41.49%
3.67 M EQUITY
-46.97%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Protagenic Therapeutics, Inc.
image
Current Assets 4.2 M
Cash & Short-Term Investments 4.06 M
Receivables 0
Other Current Assets 144 K
Non-Current Assets 123 K
Long-Term Investments 0
PP&E 123 K
Other Non-Current Assets 0
Current Liabilities 655 K
Accounts Payable 114 K
Short-Term Debt 0
Other Current Liabilities 541 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Jul-2005 Jul-2004 Jul-2003 Jul-2002 Jul-2001 Jul-2000 Jul-1999 Jul-1998 Jul-1997 Jul-1996 Jul-1995
ASSETS
Cash & Cash Equivalents 1.3 0.2 0.5 0.7 0.8 0.4 0.4 3.1 62 K 0.1 0.7 6.3 16.9 20.4 7.6 0.5 0 4.5 100 K 11 K 16 K 0 0.1 34 K 0.3 0.1 0.5
Short Term Investments 2.8 7.8 9.8 0 0 0.3 1.3 0 0 0 0 0 0 4.2 2.8 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 5.4 12.4 19.5 9.1 3.5 0 2.2 2.9 4.2 5.8 6.2 6.1 4.9 2.8 2.5 1.7
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 5.4 6.8 7.0 6.6 7.1 6.7 4.9 3.5 2.7
Other Current Assets 0.1 56.9 K 0.7 0.2 43.4 K 83.4 K 94.5 K 60.4 K 70 K 0.1 0.2 0.6 2.6 3.7 1.6 0.9 0 12 K 0.1 1.0 0.9 0.9 1.0 1.3 0.9 0.3 0.3
Total Current Assets 4.2 8.0 11.1 0.9 0.8 0.7 1.8 3.2 0.1 0.2 1.0 12.3 31.9 47.8 21.1 5.0 0 7.0 8.6 12.1 13.8 13.7 14.4 13.0 9.0 6.3 5.2
PP&E 0.1 1.78 K 0 0 296 611 1.02 K 1.1 K 1 K 1 K 0.38 2.7 3.6 3.5 0.9 0.1 0 0 3.1 0.2 0.3 0.2 0.2 0.2 0.3 2.9 2.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 3.1 7.3 12.5 0.6 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1 0 0 0 0 0 2.5 2.7 2.9 3.1 3.3 3.1 3.2 3.4
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 1.0 1.9 2.5 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0 0 0 3.06 0 0 1.3 1.1 0.4 0 0 2.1 6.5 6.3 5.5 5.2 4.9 3.4 0.1 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 3.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 4.3 8.0 11.1 0.9 0.8 0.7 1.8 3.2 0.1 0.2 1.0 19.3 44.6 78.8 24.0 5.5 0 7.0 13.7 21.5 23.3 22.4 22.9 21.5 15.8 12.6 11.1
LIABILITIES
Accounts Payable 0.1 0.2 0.3 0.1 0.2 10 K 11 K 13.4 K 0.2 0.1 15.6 4.5 6.3 7.2 3.3 2.9 50 K 0.3 0 0 0 0 0 0 2.3 0 0
Short Term Debt 0 0.3 0 0 0 0 0 0 0 0 2.6 0 0 1.9 99 K 0 44 K 0 4.0 4.3 4.9 4.1 5.5 3.9 0 2.7 2.0
Other Current Liabilities 0.5 0.6 0.5 0.5 1.0 0.9 0.6 0.7 21 K 3 K 0 5.5 9.6 13.9 2.9 1.4 470 82 K 4.7 4.3 4.8 4.5 4.2 3.7 0.2 2.3 1.6
Total Current Liabilities 0.7 1.1 0.8 0.7 1.2 0.9 0.6 0.7 0.2 0.1 18.2 10.3 16.6 24.1 7.1 4.3 94.5 K 0.4 8.8 8.7 9.7 8.6 9.7 7.5 2.5 5.0 3.6
Long Term Debt 0 0 0.3 1.4 0.3 0 0 0 0.5 0.2 0 0 0 0 22 K 0 0 0 0 0 0 0.4 0 0 0 0.5 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0.9 1.0 0 0 0 0 3.8 4.0 0 0 0 0 0 0 0 2.0
Total Liabilities 0.7 1.1 1.1 2.0 1.5 0.9 0.6 0.7 0.7 0.3 18.2 11.2 19.3 24.1 7.1 4.3 94.5 K 4.2 8.8 8.7 9.7 8.9 9.7 7.5 2.5 5.5 3.6
EQUITY
Common Stock 444 434 1.72 K 1.04 K 1.03 K 1.03 K 1.03 K 1.03 K 0.761 7.61 1.0 70 K 0.2 0.2 0.1 73 K 0.3 34.8 K 40 K 35 K 35 K 35 K 35 K 35 K 35 K 10 K 10 K
Retained Earnings (30.8) (25.8) (22.2) (17.7) (15.2) (13.4) (10.8) (8.6) (1.6) (1.1) (195.5) (168.0) (148.3) (118.8) (3.1) 1.1 94.5 K (13.9) (11.7) (3.8) (3.0) (3.2) (4.3) (3.6) (4.3) (3.1) (2.0)
Other Accumulative Comprehensive Income/Loss (0.1) (0.7) (0.2) (0.2) (0.2) (0.2) (0.2) (0.2) 149 148 8.76 42 K 20 K (0.3) 38 K 0 0 0 (1.0) 0 0 0 0 0 0 (0.2) 90 K
Total Equity 3.7 6.9 9.9 (1.1) (0.6) (0.2) 1.2 2.5 (0.6) 70 K (17.2) 8.2 25.3 54.6 16.9 1.2 94.5 K 2.7 5.0 12.9 13.6 13.4 13.3 13.9 13.3 7.0 7.5
Total Liabilities and Equity 4.3 8.0 11.1 0.9 0.8 0.7 1.8 3.2 0.1 0.2 1.0 19.3 44.6 78.8 24.0 5.5 0 7.0 13.7 21.5 23.3 22.4 22.9 21.5 15.8 12.6 11.1
SHARES OUTSTANDING
Common Shares Outstanding 4.3 4.3 3.7 2.6 2.6 2.6 2.6 1.3 6.5 K 6.47 K 1.62 K 102 84 86 49 1 1 4.2 4.2 1 1 1 1 1 1 4.2 4.2